Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.
about
Genetic incorporation of human metallothionein into the adenovirus protein IX for non-invasive SPECT imagingUnique sequence features of the Human adenovirus 31 complete genomic sequence are conserved in clinical isolatesPhage display of random peptide libraries: applications, limits, and potential.A novel method for generating and screening peptides and libraries displayed on adenovirus fiberAdenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo.Derivation of a triple mosaic adenovirus for cancer gene therapy.Adenoviral vector immunity: its implications and circumvention strategies.Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection.HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.Identification of sites in adenovirus hexon for foreign peptide incorporation.Effective modifications for improved homologous recombination and high-efficiency generation of recombinant adenovirus-based vectors.Novel adenovirus vectors 'capsid-displaying' a human complement inhibitor.Adenovirus receptors and their implications in gene deliveryDetection of antibodies against adenovirus protein IX, fiber, and hexon in human sera by immunoblot assay.Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX.Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy (Review)Current strategies and future directions for eluding adenoviral vector immunityChapter two--Adenovirus strategies for tissue-specific targeting.Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunityAvidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector.Cryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX.Transductional targeting of adenovirus vectors for gene therapyCore labeling of adenovirus with EGFP.Utilizing the antigen capsid-incorporation strategy for the development of adenovirus serotype 5-vectored vaccine approaches.Oncolytic adenoviruses - selective retargeting to tumor cells.Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform.Current advances and future challenges in Adenoviral vector biology and targetingOncolytic adenoviruses as antiglioma agents.A Novel Vaccine Approach for Chagas Disease Using Rare Adenovirus Serotype 48 Vectors.Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer modelTargeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.Adenoviral vector-based strategies for cancer therapy.Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer.Strategies to overcome host immunity to adenovirus vectors in vaccine development.Oncolytic (replication-competent) adenoviruses as anticancer agents.Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.Viruses - from pathogens to vaccine carriersTropism-modification strategies for targeted gene delivery using adenoviral vectors.
P2860
Q28742934-7B6A60CF-8D97-4F60-9B96-01F6A42E79EDQ30917597-CEADAA13-C767-4255-AB4B-7666F392F5C8Q31039269-22A04E04-5421-4BED-996A-095D3EA8FD51Q33304147-3E4024E3-A0FA-4790-B917-6E617551133BQ33389860-E22D9A6B-7094-4B05-AC7A-B1262FDD81D6Q33521705-DA2EDB2D-C2D9-43BF-BC9A-301AFC845939Q33565630-6CF790EB-8314-4B86-9CDC-87103B59F6B6Q33614622-FC4BEE20-5153-46E7-B011-56A3C5D2DDA9Q33646773-E4350482-7795-4445-98E2-67DBCC0BE55FQ33737591-1296341C-5018-483A-932A-49EB6DA567F8Q33770522-F8CFD4C2-0851-49D7-8BF1-D0A15205CFD8Q33955918-A4CA62CD-2A1D-447B-AA77-143DB40A1831Q33994011-C1A407AE-CE28-423E-8C29-8F93EA2DD799Q34042482-0711CE52-209A-43E1-852C-2E0BA10E0096Q34120709-E5AD449F-1E23-4C1F-AE9F-221655C8101DQ34123275-9EF847B4-D5E2-45C2-8CC7-6F3F232E9ED9Q34352485-964EE207-B487-47B4-ADEE-41FC40468C7EQ34433546-7E488099-9B54-48D6-872D-E2171F4ADACDQ34585554-2A350606-6CEA-4323-9DEB-B85323470A57Q34643252-D9A88F11-2E4B-432D-BEBB-12AA842767BCQ34648154-2A21D71C-06E3-43AB-BA2E-D9E2F372C8B7Q35019399-1BC51CDB-B709-4BBA-B8A9-D4A9D3B11A6DQ35140014-98D4B88F-D8C8-48B2-B301-441DC9C28805Q35609035-0091A225-4FCB-4108-87AC-64FED71FB7CCQ35609040-76672C04-FD4F-429E-B78C-57B7BD576490Q35973091-404DF1B8-5192-430E-A726-C5A64375FC91Q36318189-D783A65C-DC15-4BF6-97CD-E39921723BC1Q36330007-E4299119-4BB0-4CCB-B453-8A25FACCEB39Q36463004-0AF75D2A-519F-49A2-948B-CFBB0E1A546CQ36499227-1FD319AB-BCC9-430E-B00D-F443A4636E0AQ36735672-7A703CF2-ACC4-4C80-9B4A-EA315E90E531Q37127836-03398517-DFE7-49E5-B490-5EE6EFC51F34Q37227135-24E9E106-EF7A-43C2-9C46-D8DC83CB1088Q37409025-CF25AF00-F164-48E2-A57B-25132E7DDF3BQ37481753-9B3F5CCB-C792-4840-9301-DF043F2037E0Q37503253-38AEC848-A966-4257-B3F8-65E854409046Q37687415-AAD002C7-AA23-464A-81D9-5641C1FF5BD7Q37806749-405E7346-7548-40F5-A496-A2A0C0E26DDFQ37946370-D9D54898-B229-4941-A4EE-12EC8851C426Q38614156-FBE193EF-261A-494E-B16D-83B7F9D92779
P2860
Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Engineering of adenovirus vect ...... terminus of capsid protein IX.
@ast
Engineering of adenovirus vect ...... terminus of capsid protein IX.
@en
Engineering of adenovirus vect ...... terminus of capsid protein IX.
@nl
type
label
Engineering of adenovirus vect ...... terminus of capsid protein IX.
@ast
Engineering of adenovirus vect ...... terminus of capsid protein IX.
@en
Engineering of adenovirus vect ...... terminus of capsid protein IX.
@nl
prefLabel
Engineering of adenovirus vect ...... terminus of capsid protein IX.
@ast
Engineering of adenovirus vect ...... terminus of capsid protein IX.
@en
Engineering of adenovirus vect ...... terminus of capsid protein IX.
@nl
P2860
P1433
P1476
Engineering of adenovirus vect ...... terminus of capsid protein IX.
@en
P2093
Elena A Kashentseva
Igor P Dmitriev
P2860
P304
P356
10.1128/JVI.76.14.6893-6899.2002
P407
P577
2002-07-01T00:00:00Z